Science, medicine and industry: are we getting out of the black hole in sepsis research?

Intensive Care Med. 2008 Nov;34(11):1950-4. doi: 10.1007/s00134-008-1302-6. Epub 2008 Oct 7.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-Infective Agents / therapeutic use*
  • Clinical Trials, Phase III as Topic / ethics
  • Clinical Trials, Phase III as Topic / methods
  • Drug Industry / ethics
  • Humans
  • Multicenter Studies as Topic / ethics
  • Multicenter Studies as Topic / methods
  • Placebos
  • Protein C / therapeutic use*
  • Randomized Controlled Trials as Topic / ethics
  • Randomized Controlled Trials as Topic / methods
  • Recombinant Proteins / therapeutic use
  • Research Design*
  • Shock, Septic / drug therapy*
  • Shock, Septic / mortality
  • United States / epidemiology
  • United States Food and Drug Administration

Substances

  • Anti-Infective Agents
  • Placebos
  • Protein C
  • Recombinant Proteins
  • drotrecogin alfa activated